Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00005133 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cardiovascular Health Study (CHS)

Study acronym: CHS
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Oct 31, 2027 to Dec 31, 2027v14
  2. Primary completion date: Aug 1, 2024 to Oct 31, 2027 Completion date: Oct 31, 2024 to Oct 31, 2027 · Site details revised at 1 of 6 sitesv13 Show 2 more changesShow less
    • Completion date: Oct 31, 2024 to Oct 31, 2027
    • Site details revised at 1 of 6 sites
  3. Study sites: 1 to 6v12
  4. Primary completion date: Dec 2023 to Aug 1, 2024v11
  5. 2 versions Re-verified since Jan 30, 2023, no change to tracked fieldsv9-v10
Show 7 earlier versionsHide 7 earlier versions
  1. Primary completion date: May 2009 to Dec 2023 Trial status: Completed to Active, Not Recruiting · Enrollment target: 5888 · Study sites: 0 to 1 · 4 morev8 Show 7 more changesShow less
    • Trial status: Completed to Active, Not Recruiting
    • Enrollment target: 5888
    • Study sites: 0 to 1
    • Completion date: May 2009 to Oct 31, 2024
    • Eligibility criteria expanded, about 95 words
    • Study description shortened, about 169 words
    • Collaborators expanded, about 9 words

    See this version in full on ClinicalTrials.gov ↗

  2. Re-verified, no change to tracked fieldsv7
  3. Trial status: Active, Not Recruiting to Completed Primary completion date: May 2009v6 Show 1 more changeShow less
    • Primary completion date: May 2009
  4. Publications: 16 to 15v5 See this version in full on ClinicalTrials.gov ↗
  5. Re-verified, no change to tracked fieldsv4
  6. Completion date: Oct 2005 to May 2009 Study description revisedv3 Show 1 more changeShow less
    • Study description revised

    See this version in full on ClinicalTrials.gov ↗

  7. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
National Heart, Lung, and Blood Institute (NHLBI)
135 trials monitored
See 11 trials at risk
Diabetes
4,286 trials monitored
See 185 trials at risk
Stroke
3,289 trials monitored
See 140 trials at risk
Heart Disease
2,136 trials monitored
See 107 trials at risk
and 2 more diseases
To determine the extent to which known risk factors predict coronary heart disease and stroke in the elderly, to assess the precipitants of coronary heart disease and stroke in the elderly, and to identify the predictors of mortality and functional impairments in clinical coronary disease or stroke.
Trial Details
NCT Number NCT00005133
Lead Sponsor National Heart, Lung, and Blood Institute (NHLBI)
Collaborators: University of Washington, the Collaborative Health Studies Coordinating Center
Conditions Cardiovascular Diseases, Coronary Disease, Heart Diseases, Cerebrovascular Accident, Diabetes Mellitus, Hypertension, Heart Failure, Congestive
Enrollment 5,888 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov